Cargando…
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice
The COVID-19 pandemic dramatically demonstrated the need for improved vaccination strategies and therapeutic responses to combat infectious diseases. However, the efficacy of vaccines has not yet been demonstrated in combination with commonly used immunosuppressive drug regimens. We sought to determ...
Autores principales: | Paschall, Amy V., Ozdilek, Ahmet, Briner, Sydney L., Brindley, Melinda A., Avci, Fikri Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718886/ https://www.ncbi.nlm.nih.gov/pubmed/34991929 http://dx.doi.org/10.1016/j.vaccine.2021.12.058 |
Ejemplares similares
-
Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens
por: Ozdilek, Ahmet, et al.
Publicado: (2020) -
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies
por: Ozdilek, Ahmet, et al.
Publicado: (2021) -
Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help
por: Sun, Lina, et al.
Publicado: (2020) -
Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design
por: Duke, Jeremy A., et al.
Publicado: (2021) -
Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase
por: Paschall, Amy V., et al.
Publicado: (2020)